Short courses will be held Wednesday, September 12, for an additional fee of $105 ($110 after August 1) each.
Morning Short Courses – 8:30 a.m. – 12:00 p.m.
SC1: Bayesian Dynamic Borrowing of Historical Data to Boost the Inferential Power of New Clinical Trials: A Workshop to Review Methods and Understand Benefits and Risks, Nicky Best, GSK
SC2: Statistical Methods for the Co-Development of Drug and Companion Diagnostic, Meijuan Li, FDA/CDRH; Rui Tang, Shire Inc.; Liang Fang, MyoKardia Inc.
SC3: A Principled Approach to Multiple Comparisons for Making Decisions, Especially for Targeted Therapies, Frank Bretz, Novartis; Jason Hsu, The Ohio State University; Yi Liu, Takeda
SC4: Efficient Statistical Simulation Designs in SAS and R with Graphical Analytics, Mehmet Kocak, The University of Tennessee Health Science Center
Afternoon Short Courses – 1:30 p.m. – 5:00 p.m.
SC5: Statistical and Strategic Considerations in Development of Oncology Immunotherapies, Cong Chen, Merck & Co., Inc.
SC6: Missing Data Analysis in Clinical Trials Using SAS®, Frank Liu, Merck & Co., Inc.; Fang Chen, SAS Institute Inc.
SC7: Artificial Intelligence in Drug Development: Analyzing Electronic Medical Records Using Deep Learning, Qi Tang, Sanofi
SC8: Adaptive Enrichment Trial Designs: Statistical Methods, Trial Optimization Software, and Four Case Studies, Michael Rosenblum, The Johns Hopkins University